UNSPSC 51285507: Heliomycin

This classification denotes an antibiotic with the molecular formula C22H16O6, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 7N3A092A5X, chemically known as 2h-benzo(cd)pyrene-2,6(1h)-dione, 3,5,7,10-tetrahydroxy-1,1,9-trimethyl- but more generally known as heliomycin, which bears U.S. National Institutes of Health Compound Identifier 5282060. The European Medicines Agency schedules Heliomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08013MIG.

UNSPSC 51285507 Heliomycin is a Commodity code that does not match the work actually being solicited under recent state and local opportunities tagged to it. The recent opportunities show procurement of naloxone, safe drug deactivation systems, medical and first aid supplies for emergency response, generic pharmaceuticals and over-the-counter products, and direct-to-manufacturer prescription programs — none of which are heliomycin or antibiotics. The code's nominal scope does not align with the diverse health-supply and pharmacy-benefit work being bought today, suggesting either miscoding by issuing bodies or a mismatch between the taxonomy and current procurement practice under this code.

The issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal purchasing for emergency services (City of Tampa Fire Department), and cooperative purchasing alliances serving multiple jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance with participants in Minnesota and Oregon). Recent opportunities range from an IFB for naloxone and drug deactivation systems with a response deadline of July 26, 2023 (Seminole County), to an RFI on direct-to-manufacturer prescriptions for the Texas HHS Commission (response due April 3, 2026), to an IFB for medical and first aid supplies for the Tampa Fire Department with an estimated contract amount of $700,000 and a March 13, 2026 response deadline, to an RFP by the Minnesota Multistate Cooperative Purchasing Alliance for generic pharmaceuticals and OTC products with a March 26, 2026 proposal deadline. The geographic spread spans Florida, Texas, Minnesota, and Oregon. The code shows little relevant recent activity aligned to its stated commodity name.